SQA
AGIO icon

Simon Quick Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Simon Quick Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$42K – 336
2016
Q4 		$42K Buy
+1,000
New +$52.5K 0.03% 165

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Simon Quick Advisors's AGIO Position: Q1 2017 in Review

Simon Quick Advisors sold out of Agios Pharmaceuticals (AGIO) in Q1 2017, closing a stake of 1,000 shares — an estimated $42K sold.

Simon Quick Advisors first reported a position in AGIO in Q4 2016 and held it in 1 quarter. The position peaked at $42K in Q4 2016. 156 funds tracked by Wall St. Rank hold AGIO as of Q1 2017.

  • Simon Quick Advisors reported no remaining Agios Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Simon Quick Advisors sold 1,000 Agios Pharmaceuticals shares in Q1 2017, an estimated $42K.
  • Simon Quick Advisors first reported a position in Agios Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Simon Quick Advisors's Agios Pharmaceuticals position peaked at $42K in Q4 2016.
  • 156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2017.

Based on Simon Quick Advisors's 13F filing for Q1 2017, filed 11 May 2017.